Iva Holmerová1, Jakub Hort2, Robert Rusina3, Anders Wimo4, Michal Šteffl5. 1. Faculty of Humanities, Centre of Expertise Longevity and Long Term Care and Centre of Gerontology, Charles University Prague, Prague, Czech Republic. 2. Department of Neurology, Faculty of Medicine 2, Memory Clinic, Charles University Prague, Prague, Czech Republic. 3. Department of Neurology, Faculty of Medicine 1, Charles University Prague, Prague, Czech Republic. 4. Division of Neurogeriatrics, Department of Neurobiology Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Huddinge, Sweden. 5. Faculty of Physical Education and Sport, Charles University Prague, Veleslavin, 16252 6, Prague, Czech Republic. steffl@ftvs.cuni.cz.
Abstract
OBJECTIVE: The aim of this study was to estimate the cost of dementia in the Czech Republic. METHODS: One hundred and nineteen patient-caregiver dyads participated in our multicenter observational cost-of-illness study. The modified Resource Utilization in Dementia Questionnaire was used as the main tool to collect data from patients and caregivers. Medical specialists provided additional data from medical records. The average costs of dementia were calculated and patients were then divided by the level of cognitive impairment. A generalized linear model was used to determine if differences were present for selected cost variables. RESULTS: The mean (standard deviation) for direct cost per a patient in a month was estimated to be €243.0 (138.0), €1727.1 (1075.6) for the indirect cost, and €1970.0 (1090.3) for the total cost of dementia in the Czech Republic. All of the costs increased as dementia severity increased. Both the indirect and total costs significantly (p < 0.05) increased if patients were living with their primary caregiver, and if the severity of cognitive impairment was increased. CONCLUSIONS: The indirect cost, which was represented mainly by informal care, comprised the main part of the total cost of care for patients with dementia in the Czech Republic. Both total and indirect care costs increased significantly the cognition declined.
OBJECTIVE: The aim of this study was to estimate the cost of dementia in the Czech Republic. METHODS: One hundred and nineteen patient-caregiver dyads participated in our multicenter observational cost-of-illness study. The modified Resource Utilization in Dementia Questionnaire was used as the main tool to collect data from patients and caregivers. Medical specialists provided additional data from medical records. The average costs of dementia were calculated and patients were then divided by the level of cognitive impairment. A generalized linear model was used to determine if differences were present for selected cost variables. RESULTS: The mean (standard deviation) for direct cost per a patient in a month was estimated to be €243.0 (138.0), €1727.1 (1075.6) for the indirect cost, and €1970.0 (1090.3) for the total cost of dementia in the Czech Republic. All of the costs increased as dementia severity increased. Both the indirect and total costs significantly (p < 0.05) increased if patients were living with their primary caregiver, and if the severity of cognitive impairment was increased. CONCLUSIONS: The indirect cost, which was represented mainly by informal care, comprised the main part of the total cost of care for patients with dementia in the Czech Republic. Both total and indirect care costs increased significantly the cognition declined.
Entities:
Keywords:
Alzheimer’s disease; Direct medical care; Indirect expenses; Informal care; Social care
Authors: Secundino López-Pousa; Josep Garre-Olmo; Antoni Turon-Estrada; Francisco Hernández; Inmaculada Expósito; Manoli Lozano-Gallego; Marta Hernández-Ferrándiz; Esther Gelada-Batlle; Imma Pericot-Nierga; Joan Vilalta-Franch Journal: Med Clin (Barc) Date: 2004-05-29 Impact factor: 1.725
Authors: Nadège Costa; Laura Ferlicoq; Hélène Derumeaux-Burel; Thomas Rapp; Valérie Garnault; Sophie Gillette-Guyonnet; Sandrine Andrieu; Bruno Vellas; Michel Lamure; Alain Grand; Laurent Molinier Journal: Biomed Res Int Date: 2012-12-05 Impact factor: 3.411
Authors: Youssef H El-Hayek; Ryan E Wiley; Charles P Khoury; Ritesh P Daya; Clive Ballard; Alison R Evans; Michael Karran; José Luis Molinuevo; Matthew Norton; Alireza Atri Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472